Sevoflurane/Dexmedetomidine Vs. Isoflurane for Pediatric Emergence Delirium
- Registration Number
- NCT06624592
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 400
- Pediatric patients aged 2-7 years.
- Surgeries include ENT cases (i.e., tonsillectomy/adenoidectomy), ophthalmology cases (i.e., strabismus), and urology cases.
- Can be outpatient or General Care inpatient procedures.
- All cases must include an IV and an endotracheal tube (ETT).
- Severe developmental/cognitive delay (unable to make eye contact, nonverbal, or inability to interact with providers for PAED scale assessment requirements)
- TIVA cases.
- No PIV in place during the case, planned PICU admission postoperatively.
- Previous history of severe emergence delirium documented by a provider (via interventions or explicitly stated).
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Isoflurane group Isoflurane - Sevoflurane group Sevoflurane -
- Primary Outcome Measures
Name Time Method Number of subjects with emergence delirium Within 1 hour after dropped off by anesthesiology team Total number of subjects with a Pediatric Anesthesia Emergence Delirium (PAED) score of \> 10. The PAED scale consists of 5 criteria that are scored using a 5-point scale. The scores of each criterion are added to make a total score. The maximum achievable total score is 20.
- Secondary Outcome Measures
Name Time Method Post Anesthesia Care Unit (PACU) length of stay Post-procedural (0-4 hours after anesthesiology drop off) Number of hours spent in PACU during recovery
Trial Locations
- Locations (1)
Mayo Clinic in Rochester
🇺🇸Rochester, Minnesota, United States